SCHEMBL24192572

SCHEMBL24192572

CC(C)(C)OC(=O)NCCOc1cc(F)ccc1B1OC(C)(C)C(C)(C)O1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.43
AAK1 Q2M2I8 2/20 0.41
PDK2 Q15119 1/20 0.41
CA12 O43570 3/20 0.41
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA9 Q16790 3/20 0.41
PRMT5 O14744 1/20 0.41
WDR77 Q9BQA1 1/20 0.41
CXCR2 P25025 1/20 0.37
AXL P30530 1/20 0.37
CYP1A1 P04798 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2B6 P20813 1/20 0.37
CYP2C19 P33261 1/20 0.37
CYP3A43 Q9HB55 1/20 0.37
IDO1 P14902 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
BRD4 O60885 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31371697 0.94 BCHE (0.41) SCN9AAAK1PDK2CA12CA1
SCHEMBL24192558 0.92 SCN9A (0.43) SCN9AAAK1PDK2CA12CA1
SCHEMBL24192454 0.87 SCN9A (0.46) SCN9AAAK1PDK2CA12CA1
SCHEMBL31583589 0.87 CA12 (0.45) AAK1PDK2CA12CA1CA2
SCHEMBL24191752 0.84 CA12 (0.45) SCN9AAAK1PDK2CA12CA1
SCHEMBL30417685 0.84 CA12 (0.45) SCN9AAAK1PDK2CA12CA1
SCHEMBL31584226 0.81 BCHE (0.45) AAK1PDK2CA12CA1CA2
SCHEMBL30151792 0.81 SCN9A (0.52) SCN9AAAK1PDK2CA12CA1
SCHEMBL23848044 0.81 SCN9A (0.52) SCN9AAAK1PDK2CA12CA1
SCHEMBL2467236 0.81 CA12 (0.46) SCN9AAAK1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257396-A1 MACROCYCLES AND THEIR USE BLOSSOMHILL THERAPEUTICS INC (US) 2023-08-17 US disclosed
US-20230257396-A1 MACROCYCLES AND THEIR USE BLOSSOMHILL THERAPEUTICS INC (US) 2023-08-17 US disclosed
WO-2022011123-A1 MACROCYCLES AND THEIR USE BLOSSOMHILL THERAPEUTICS, INC. (US) 2022-01-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257396-A1 MACROCYCLES AND THEIR USE VHL, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, DLD SCN9A 4694/4885AAK1 4411/4885PDK2 580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.